Application of Anti-Tuberculosis Drug-Metabolising Enzyme Inhibition and Polymorphisms Improve Anti-Tuberculosis Drug-Induced Hepatotoxicity
博士 === 國防醫學院 === 生命科學研究所 === 101 === Backgrounds and Aims: Tuberculosis (TB) is the second leading cause of death from an infectious disease worldwide, after the human immunodeficiency virus (HIV). Drug-induced adverse effects: isoniazid (INH), rifampin (RIF) and pyrazinamide (PZA) may induce hepati...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2013
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/42515298185887675627 |
